Inhibitors of hepatitis C virus

The invention relates to compounds of Formula IV:IV,as well as pharmaceutically acceptable salts thereof and pharmaceutical compositions containing such compounds. The invention also relates to medical uses of said compounds and a method of treating hepatitis C virus infection. Invenţia se referă la...

Full description

Saved in:
Bibliographic Details
Main Authors KARKI Kapil Kumar, SCHRIER Adam James, TRAN Chinh Viet, COTTELL Jeromy J, KOBAYASHI Tetsuya, KATANA Ashley Anne, CANALES Eda, LINK John O, MARTINEZ Ruben, VIVIAN Randall W, ZIPFEL Sheila, BJORNSON Kyla, YANG Zheng-Yu, KATO Darryl, SANGI Michael, PHILLIPS Barton W, SIEGEL Dustin, TAYLOR James G, TREJO MARTIN Teresa Alejandra, ZABLOCKI Jeff, PYUN Hyung-Jung
Format Patent
LanguageEnglish
Romanian
Russian
Published 30.11.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to compounds of Formula IV:IV,as well as pharmaceutically acceptable salts thereof and pharmaceutical compositions containing such compounds. The invention also relates to medical uses of said compounds and a method of treating hepatitis C virus infection. Invenţia se referă la compuşi cu formula IV:IV,precum şi la sărurile acceptabile farmaceutic ale acestora şi la compoziţii farmaceutice care conţin aceşti compuşi. Invenţia se referă, de asemenea, la utilizări medicale a acestor compuşi şi la o metodă de tratament al infecţiei cu virusul hepatitei C. Изобретение относится к соединениям формулы IV:IV,а также к их фармацевтически приемлемым солям и к фармацевтическим композициям, содержащим эти соединения. Изобретение также относится к медицинским применениям указанных соединений и к способу лечения инфекции вируса гепатита С.
Bibliography:Application Number: MD20140000136